HEPARIN INDUCED THROMBOCYTOPENIA AND HEMODIALYSIS

Authors

  • AMAL S. ELHASSADE
  • AHLAM MOHAMED BEN NASER

Abstract

Unfractionated heparin is the most commonly used anticoagulant for hemodialysis (HD).  It is well-known that heparin can cause immune-mediated thrombocytopenia due to immunoglobulin antibody formation against the complex of platelet factor 4 (PF4) and heparin. Heparin may also contribute to HD-associated platelet activation, thrombocytopenia, and increased PF4 release from platelets during a heparin dialytic session. The present study was conducted to study the effect of unfraction heparin as anticoagulant in newly treatment hemodialysis patients. Material and method: A sample of 72 people were selected, 32 patients on dialysis for first time from unite of kidney dialysis. At the same time a group of 40 randomly selected healthy adults to participate in the study as control. By Automated cell counter (sysmex X 21) platelets from all patients on dialysis before starting heparin and after one month later were estimated. Result: The mean value of platelets in patients after treated with heparin was significant lower (192.3 ± 20.7 ) — 109/l as compare before treated with heparin 203 ± 20.7 — 109/l  ( P = 0.001). Conclusion: From this study, heparin as anti-coagulant has effect on decrease platelets count but still patients have no thrombocytopenia platelets level 150 — 109/l.h

Downloads

Download data is not yet available.

Downloads

Published

2016-10-19

Issue

Volume 2, Issue 4; October 2016

Section

Original Research Articles

License

The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.

The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.

What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:

  • The journal allows the author(s) to hold the copyright without restrictions.
  • The journal allows the author(s) to obtain publishing rights without restrictions.
  • You may do whatever you wish with the version of the article you submitted to the journal.
  • Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
  • You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
  • You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.